These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23375015)

  • 1. Advances in the mechanisms of Parkinson's disease.
    Tolleson CM; Fang JY
    Discov Med; 2013 Jan; 15(80):61-6. PubMed ID: 23375015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides.
    Dardiotis E; Xiromerisiou G; Hadjichristodoulou C; Tsatsakis AM; Wilks MF; Hadjigeorgiou GM
    Toxicology; 2013 May; 307():17-23. PubMed ID: 23295711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of iron in the pathogenesis of Parkinson's disease.
    Sian-Hülsmann J; Mandel S; Youdim MB; Riederer P
    J Neurochem; 2011 Sep; 118(6):939-57. PubMed ID: 21138437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in Parkinson's disease and other neurodegenerative disorders.
    Jenner P
    Pathol Biol (Paris); 1996 Jan; 44(1):57-64. PubMed ID: 8734302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?
    Michel PP; Ruberg M; Hirsch E
    Sci STKE; 2006 Apr; 2006(332):pe19. PubMed ID: 16639033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.
    Mandel SA; Fishman T; Youdim MB
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S242-7. PubMed ID: 18267243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between environmental and genetic factors in the pathophysiology of Parkinson's disease.
    Tsang F; Soong TW
    IUBMB Life; 2003 Jun; 55(6):323-7. PubMed ID: 12938734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic contributions to Parkinson's disease.
    Huang Y; Cheung L; Rowe D; Halliday G
    Brain Res Brain Res Rev; 2004 Aug; 46(1):44-70. PubMed ID: 15297154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular models to investigate biochemical pathways in Parkinson's disease.
    Alberio T; Lopiano L; Fasano M
    FEBS J; 2012 Apr; 279(7):1146-55. PubMed ID: 22314200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's syndrome and Parkinson's disease in mitochondrial disorders.
    Finsterer J
    Mov Disord; 2011 Apr; 26(5):784-91. PubMed ID: 21384429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What process causes nigral cell death in Parkinson's disease?
    Jenner P
    Neurol Clin; 1992 May; 10(2):387-403. PubMed ID: 1584181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron transport in Parkinson's disease.
    Hirsch EC
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of Parkinson's disease.
    Sherer TB; Betarbet R; Greenamyre JT
    Curr Opin Investig Drugs; 2001 May; 2(5):657-62. PubMed ID: 11569943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
    Zhang Y; Dawson VL; Dawson TM
    Neurobiol Dis; 2000 Aug; 7(4):240-50. PubMed ID: 10964596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Free radicals and ailing proteins--the culprits behind Parkinson disease?].
    Smith R; Lotharius J; Brundin P
    Lakartidningen; 2003 Apr; 100(15):1324-6, 1329-30. PubMed ID: 12739402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease: piecing together a genetic jigsaw.
    Dekker MC; Bonifati V; van Duijn CM
    Brain; 2003 Aug; 126(Pt 8):1722-33. PubMed ID: 12805097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial oxidative phosphorylation defects in Parkinson's disease.
    Shoffner JM; Watts RL; Juncos JL; Torroni A; Wallace DC
    Ann Neurol; 1991 Sep; 30(3):332-9. PubMed ID: 1952821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathogenesis of Parkinson's disease.
    Gandhi S; Wood NW
    Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies.
    Bisaglia M; Greggio E; Beltramini M; Bubacco L
    FASEB J; 2013 Jun; 27(6):2101-10. PubMed ID: 23463698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.